The Achilles study was designed as a single-arm study and was powered for the primary objective of assessing pain control using validated pain questionnaires and tumor-induced bone turnover using biomarkers such as C-telopeptide (CTx) and bone-secreted alkaline phosphatase (BSAP) [27]. Here, CYP27A1 is linked to neoplasm.